Assessment times for authorisation of parallel import of medicines
Status for 2026 as at end-June 2026: In 2026, the share of cases assessed within the target time has been 95%, while in 2025 it was 97%.
94 % of the cases finished within the performance requirement's maximum of 60 days (average assessment time is 53 days):
- Human medicines: 95 % of the cases finished within the performance requirement's maximum of 60 days (53 days on average).
- Veterinary medicines: no parallel import cases have been completed for veterinary medicines in 2026
Chart 1: Average assessment times for parallel import
See table 1-3 for parallel import
|
Table 1. Average assessment times for parallel import |
||||||
|
|
Average assessment time |
Target days |
Difference between assessment time and target days |
No. of cases measured No. of Drug IDs |
No. of cases within target |
Share of cases within target in percent |
|
Parallel import |
||||||
|
3rd quarter 2024 |
75 |
60 |
15 |
119 |
97 |
82 |
|
4th quarter 2024 |
81 |
60 |
21 |
181 |
153 |
85 |
|
1st quarter 2025 |
48 |
60 |
-12 |
110 |
107 |
97 |
|
2nd quarter 2025 |
56 |
60 |
-4 |
182 |
176 |
97 |
|
3rd quarter 2025 |
53 |
60 |
-7 |
177 |
170 |
96 |
|
4th quarter 2025 |
43 |
60 |
-17 |
201 |
194 |
97 |
|
1st quarter 2026 |
58 |
60 |
-2 |
152 |
140 |
92 |
|
2nd quarter 2026 |
48 |
60 |
-12 |
162 |
159 |
98 |
|
Table 2. Average assessment times for parallel import – Human medicines |
||||||
|
|
Average assessment time |
Target days |
Difference between assessment time and target days |
No. of cases measured No. of Drug IDs |
No. of cases within target |
Share of cases within target in percent |
|
Parallel import |
||||||
|
3rd quarter 2024 |
75 |
60 |
15 |
119 |
97 |
82 |
|
4th quarter 2024 |
81 |
60 |
21 |
181 |
153 |
85 |
|
1st quarter 2025 |
48 |
60 |
-12 |
110 |
107 |
97 |
|
2nd quarter 2025 |
56 |
60 |
-4 |
182 |
176 |
97 |
|
3rd quarter 2025 |
53 |
60 |
-7 |
177 |
170 |
96 |
|
4th quarter 2025 |
43 |
60 |
-17 |
201 |
194 |
97 |
|
1st quarter 2026 |
58 |
60 |
-2 |
152 |
140 |
92 |
|
2nd quarter 2026 |
48 |
60 |
-12 |
162 |
159 |
98 |
|
Table 3. Average assessment times for parallel import – Veterinary medicines |
||||||
|
|
Average assessment time |
Target days |
Difference between assessment time and target days |
No. of cases measured No. of Drug IDs |
No. of cases within target |
Share of cases within target in percent |
|
Parallel import |
||||||
|
3rd quarter 2024 |
132 |
60 |
72 |
1 |
0 |
0 |
|
4th quarter 2024 |
374 |
60 |
314 |
8 |
0 |
0 |
|
1st quarter 2025 |
|
60 |
|
0 |
|
|
|
2nd quarter 2025 |
128 |
60 |
68 |
4 |
2 |
50 |
|
3rd quarter 2025 |
10 |
60 |
-50 |
1 |
1 |
100 |
|
4th quarter 2025 |
|
60 |
|
0 |
|
|
|
1st quarter 2026 |
|
60 |
|
0 |
|
|
|
2nd quarter 2026 |
|
60 |
|
0 |
|
|
The assessment times are measured against the target time of 60 days, i.e. from the date when we start reviewing the application until we issue the marketing authorisation. The assessment times are net times, which means that they do not include any time periods during which we await a reply from the applicant or the export country.
For further information, please contact Send an email.